Assignee
KAI PHARMACEUTICALS INC
US·9 granted patents·15 pending applications·72 citations·filing 2005–2025
Top patents by PatentIndex Score
24 records- 0193US7265092B2Pharmaceutical formulationKAI PHARMACEUTICALS INC·Filed 2005·Granted Sep 4, 2007·37 cites·8 claims
- 0292US7727958B2Pharmaceutical formulationKAI PHARMACEUTICALS INC·Filed 2007·Granted Jun 1, 2010·12 cites·9 claims
- 0390US8377880B2Therapeutic agents for reducing parathyroid hormone levelsKAI PHARMACEUTICALS INC·Filed 2012·Granted Feb 19, 2013·9 cites·2 claims
- 0490US2025034545A1Modifications of peptide compositions to increase stability and delivery efficiencyKAI PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0587US9701712B2Therapeutic agents for reducing parathyroid hormone levelsKAI PHARMACEUTICALS INC·Filed 2016·Granted Jul 11, 2017·4 cites·17 claims
- 0684US9278995B2Therapeutic agents for reducing parathyroid hormone levelsKAI PHARMACEUTICALS INC·Filed 2013·Granted Mar 8, 2016·4 cites·41 claims
- 0784US2024116983A1Therapeutic agents for reducing parathyroid hormone levelsKAI PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0882US10077438B2Modifications of peptide compositions to increase stability and delivery efficiencyKAI PHARMACEUTICALS INC·Filed 2016·Granted Sep 18, 2018·2 cites·7 claims
- 0982US9567370B2Therapeutic agents for reducing parathyroid hormone levelsKAI PHARMACEUTICALS INC·Filed 2015·Granted Feb 14, 2017·2 cites·28 claims
- 1081US2022282239A1Modifications of peptide compositions to increase stability and delivery efficiencyKAI PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1179US8017583B2Methods of use of epsilon inhibitor compounds for the attenuation of painKAI PHARMACEUTICALS INC·Filed 2008·Granted Sep 13, 2011·2 cites·18 claims
- 1276US2025163103A1Therapeutic agents for reducing parathyroid hormone levelsKAI PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1374US2020399309A1Therapeutic agents for reducing parathyroid hormone levelsKAI PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1473US2020370032A1Modifications of peptide compositions to increase stability and delivery efficiencyKAI PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1570US2019194252A1Therapeutic agents for reducing parathyroid hormone levelsKAI PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1667US10280198B2Therapeutic agents for reducing parathyroid hormone levelsKAI PHARMACEUTICALS INC·Filed 2017·Granted May 7, 2019·0 cites·9 claims
- 1766US2018371448A1Modifications of peptide compositions to increase stability and delivery efficiencyKAI PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1864US2017114095A1Therapeutic agents for reducing parathyroid hormone levelsKAI PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1959US2014213532A1Compositions and methods for enhancing drug delivery across and into epithelial tissuesKAI PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2059US2014315809A1Calcimimetics and methods for their useKAI PHARMACEUTICALS INC·Filed 2012·Application pending·0 cites
- 2158US2017252397A1Calcimimetics and methods for their useKAI PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 2257US2014023632A1Pharmaceutical formulationKAI PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2356US2013281380A1Methods of use of epsilon inhibitor compounds for the attenuation of painKAI PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2455US2016175383A1Calcimimetics and methods for their useKAI PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when KAI PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →